Gene transfer into rabbit arteries with adeno-associated virus and adenovirus vectors

被引:55
|
作者
Gruchala, M
Bhardwaj, S
Pajusola, K
Roy, H
Rissanen, TT
Kokina, L
Kholová, I
Markkanen, JE
Rutanen, J
Heikura, T
Alitalo, K
Büeler, H
Ylä-Herttuala, S
机构
[1] Univ Kuopio, AI Virtanen Inst, Dept Biotechnol & Mol Med, FIN-70211 Kuopio, Finland
[2] Univ Zurich, Inst Mol Biol, Zurich, Switzerland
[3] Med Univ Gdansk, Dept Cardiol 1, Gdansk, Poland
[4] Univ Kuopio, Dept Med, Kuopio, Finland
[5] Kuopio Univ Hosp, Gene Therapy Unit, SF-70210 Kuopio, Finland
[6] Univ Helsinki, Haartman Inst, Mol Canc Biol Lab, Helsinki, Finland
来源
JOURNAL OF GENE MEDICINE | 2004年 / 6卷 / 05期
关键词
AAV; adenovirus; gene transfer; gene therapy; cardiovascular; artery; vector;
D O I
10.1002/jgm.535
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background Gene transfer offers considerable potential for altering vessel wall physiology and intervention in vascular disease. Therefore, there is great interest in developing optimal strategies and vectors for efficient, targeted gene delivery into a vessel wall. Methods We studied adeno-associated viruses (AAV; 9 x 10(8) to 4 x 10(9) TU/ml) for their usefulness to transduce rabbit arteries in vivo in comparison with adenoviruses (Adv; 1 x 10(9) to 1 x 10(10) pfu/ml). 100 mul of viruses or placebo solution were injected intraluminally into transiently isolated carotid segments. Results In normal arteries AAV transduced mainly medial smooth muscle cells (SMC) while Adv transduced exclusively endothelial cells (EC). Mechanical injury to EC layer and internal elastic lamina enabled Adv to penetrate and transduce medial SMC. Transgene expression in EC after the AAV-mediated gene transfer was very low. The use of the EC-specific Tie-1 promoter did not lead to specific transgene expression in EC. Transgene expression in SMC persisted for at least 100 days after the AAV treatment whereas the Adv-mediated effect diminished in 14 days. AAV caused only a modest increase in EC VCAM-1 expression and proliferation rate of vascular cells as compared with the mock-treated arteries while Adv caused an extensive inflammatory cell infiltration, VCAM-1 expression, vascular cell proliferation and morphological damages. Conclusions Significant differences were observed between the AAV and the Adv vectors in their patterns of arterial transduction and consequent inflammatory responses. These distinct properties may be utilized for different applications in vascular biology research and gene therapy for cardiovascular diseases. Copyright (C) 2004 John Wiley Sons, Ltd.
引用
收藏
页码:545 / 554
页数:10
相关论文
共 50 条
  • [1] Adenovirus and adeno-associated virus as vectors for gene therapy
    Berns, KI
    Giraud, C
    DNA VACCINES: A NEW ERA IN VACCINOLOGY, 1995, 772 : 95 - 104
  • [2] Adenovirus and adeno-associated virus vectors
    Lai, CM
    Lai, YKY
    Rakoczy, PE
    DNA AND CELL BIOLOGY, 2002, 21 (12) : 895 - 913
  • [3] Gene Transfer Targeting Mouse Vestibule Using Adenovirus and Adeno-Associated Virus Vectors
    Okada, Hiroko
    Iizuka, Takashi
    Mochizuki, Hideki
    Nihira, Tomoko
    Kamiya, Kazusaku
    Inoshita, Ayako
    Kasagi, Hiromi
    Kasai, Misato
    Ikeda, Katsuhisa
    OTOLOGY & NEUROTOLOGY, 2012, 33 (04) : 655 - 659
  • [4] Adeno-associated virus vectors for therapeutic gene transfer
    Stilwell, JL
    Samulski, RJ
    BIOTECHNIQUES, 2003, 34 (01) : 148 - +
  • [5] Adeno-associated virus vectors for gene transfer to the brain
    Okada, T
    Nomoto, T
    Shimazaki, K
    Wang, LJ
    Lu, YY
    Matsushita, T
    Mizukami, H
    Urabe, M
    Hanazono, Y
    Kume, A
    Muramatsu, S
    Nakano, I
    Ozawa, K
    METHODS, 2002, 28 (02) : 237 - 247
  • [6] Adeno-associated virus vectors for gene transfer into erythroid cells
    McCarty, DM
    Samulski, RJ
    ADENO-ASSOCIATED VIRUS (AAV) VECTORS IN GENE THERAPY, 1996, 218 : 75 - 91
  • [7] Efficacy and safety of myocardial gene transfer of adenovirus, adeno-associated virus and lentivirus vectors in the mouse heart
    Merentie, M.
    Lottonen-Raikaslehto, L.
    Parviainen, V.
    Huusko, J.
    Pikkarainen, S.
    Mendel, M.
    Laham-Karam, N.
    Karja, V.
    Rissanen, R.
    Hedman, M.
    Yla-Herttuala, S.
    GENE THERAPY, 2016, 23 (03) : 296 - 305
  • [8] Efficacy and safety of myocardial gene transfer of adenovirus, adeno-associated virus and lentivirus vectors in the mouse heart
    M Merentie
    L Lottonen-Raikaslehto
    V Parviainen
    J Huusko
    S Pikkarainen
    M Mendel
    N Laham-Karam
    V Kärjä
    R Rissanen
    M Hedman
    S Ylä-Herttuala
    Gene Therapy, 2016, 23 : 296 - 305
  • [9] GENE TARGETING WITH ADENO-ASSOCIATED VIRUS VECTORS
    Russell, David W.
    JOURNAL OF GENE MEDICINE, 2011, 13 (7-8): : 415 - 415
  • [10] Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
    Arjomandnejad, Motahareh
    Dasgupta, Ishani
    Flotte, Terence R.
    Keeler, Allison M.
    BIODRUGS, 2023, 37 (03) : 311 - 329